A listing of human tumor antigens recognized by T cells: March 2004 update (Q35862179)

10 August 2017

1 reference

title

A listing of human tumor antigens recognized by T cells: March 2004 update (English)

1 reference

10 August 2017

Luisa Novellino

1

1 reference

PubMed ID

15309328

10 August 2017

Chiara Castelli

series ordinal

2

1 reference

PubMed ID

15309328

10 August 2017

Giorgio Parmiani

series ordinal

3

1 reference

10 August 2017

7 August 2004

1 reference

Cancer Immunology, Immunotherapy

10 August 2017

1 reference

10 August 2017

54

1 reference

10 August 2017

187-207

1 reference

10 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-004-0560-6

10 August 2017

0 references

cites work

Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Sequence and expression pattern of the human MAGE2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Pre-existing immunity to tyrosinase-related protein (TRP)-2, a new TRP-2 isoform, and the NY-ESO-1 melanoma antigen in a patient with a dramatic response to immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Identification of HLA-A*0201-restricted T cell epitopes derived from the novel overexpressed tumor antigen calcium-activated chloride channel 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0560-6

10.1007/S00262-004-0560-6

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15309328